Income statement performance and balance sheet returns were largely flat across the healthcare sector in 2016, while cash flow growth showed significant improvement. The increase was fueled by healthcare equipment and supplies companies’ 18 percent year-over-year gains in cash flow growth, according to the report.
Total shareholder gains declined in 2016, which was largely attributable to stock price decreases for pharmaceutical, biotechnology and life sciences companies in the second half of last year. Although shareholder returns rose 2 percent from Nov. 7 to Dec. 30, “investors maintain a vigilant watch over the regulatory environment for the healthcare sector in 2017 due to uncertainties created by the new administration,” according to the report.
More articles on healthcare finance:
Banner’s plan to save $65M includes voluntary employee termination program
OIG: Sutter Health hospital’s errors caused $5.4M in Medicare overpayments
5 states with the most rural hospital closures
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
